Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 43.57 is 94% below its estimated 5-year average of 742.60, near the low end of its estimated 5-year range (19.25–19575.72).
As of 2026-10-06T12:05:59.034Z. 5.08% above its estimated 12-month average of 41.46.
Calculation as of: 2026-10-06T12:05:59.034Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: efaaa36d31f915a5dffaa91b800fc30e2d7f64892a7236e7a1e7b68ff3f7d584
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
43.57
PS RATIO AVG TTM
41.46
PS RATIO AVG 3Y
929.49
PS RATIO AVG 5Y
742.60
PS RATIO AVG 10Y
706.55
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+5.08%
CURRENT VS 3Y AVG
-95.31%
CURRENT VS 5Y AVG
-94.13%
CURRENT VS 10Y AVG
-93.83%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.91
median of 270 covered companies
CURRENT VS SECTOR MEDIAN
+1014.32%
vs the sector median at left
Crescent Biopharma, Inc.
Market Cap
$517.79M
PS Ratio
43.57
TTM Avg
41.46
3Y Avg
929.49
5Y Avg
742.60
Market Cap
$517.73M
PS Ratio
111.58
TTM Avg
130.95
3Y Avg
10788.70
5Y Avg
6253.86
Market Cap
$519.25M
PS Ratio
16749.86
TTM Avg
14908.47
3Y Avg
10316.98
5Y Avg
6997.34
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Crescent Biopharma, Inc. (CBIO) | $517.79M | 43.57 | 41.46 | 929.49 | 742.60 |
| Allogene Therapeutics, Inc. (ALLO)vs › | $517.73M | 111.58 | 130.95 | 10788.70 | 6253.86 |
| Altimmune, Inc. (ALT)vs › | $519.25M | 16749.86 | 14908.47 | 10316.98 | 6997.34 |
| Evolus, Inc. (EOLS)vs › | $491.93M | 1.55 | 1.38 | 2.53 | 3.18 |
| NeoGenomics, Inc. (NEO)vs › | $491.55M | 0.64 | 0.42 | 0.50 | 0.63 |
| Delcath Systems, Inc. (DCTH)vs › | $547.86M | 5.74 | 5.23 | 17.66 | 17.71 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $487.30M | N/A | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $481.33M | 1.52 | 3.28 | 9.68 | 27.67 |
| Contineum Therapeutics, Inc. (CTNM)vs › | $478.54M | N/A | 8.89 | 8.89 | 8.89 |
| CytomX Therapeutics, Inc. (CTMX)vs › | $561.67M | 30.69 | 14.58 | 5.61 | 4.40 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $10,844,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-26 |
| Q1 FY2026Period ended 2026-03-31 | $1,039,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $11,883,000 |
Current P/S: $517,786,524 market capitalization ÷ $11,883,000 TTM revenue = 43.57x.
Market capitalization source: FMP quote. Quote observed 2026-10-05T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
At 43.57, P/S is near its estimated 13-year median — higher than 44% of readings in its estimated 13-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 13-year low
1.61
median
48.45
estimated 13-year high
21865.54
P/S Ratio
43.57
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 35.82 |
| 2026-10-02 | 36.79 |
| 2026-10-01 | 36.64 |
| 2026-09-30 | 37.49 |
| 2026-09-29 | 37.92 |
| 2026-09-28 | 37.33 |
| 2026-09-25 | 35.95 |
| 2026-09-24 | 36.59 |
| 2026-09-23 | 36.46 |
| 2026-09-22 | 42.24 |
| 2026-09-21 | 41.75 |
| 2026-09-18 | 43.40 |
| 2026-09-17 | 43.09 |
| 2026-09-16 | 44.14 |
| 2026-09-15 | 48.30 |
| 2026-09-14 | 50.57 |
| 2026-09-11 | 49.87 |
| 2026-09-10 | 50.00 |
| 2026-09-09 | 51.36 |
| 2026-09-08 | 52.57 |
| 2026-09-04 | 53.65 |
| 2026-09-03 | 52.42 |
| 2026-09-02 | 47.64 |
| 2026-09-01 | 46.07 |
| 2026-08-31 | 42.65 |
| 2026-08-28 | 45.61 |
| 2026-08-27 | 45.63 |
| 2026-08-26 | 46.30 |
| 2026-08-25 | 43.68 |
| 2026-08-24 | 43.60 |
| 2026-08-21 | 44.07 |
| 2026-08-20 | 41.70 |
| 2026-08-19 | 44.50 |
| 2026-08-18 | 42.88 |
| 2026-08-17 | 44.91 |
| 2026-08-14 | 44.04 |
| 2026-08-13 | 42.73 |
| 2026-08-12 | 42.22 |
| 2026-08-11 | 42.88 |
| 2026-08-10 | 44.53 |
| 2026-08-07 | 43.27 |
| 2026-08-06 | 42.22 |
| 2026-08-05 | 40.52 |
| 2026-08-04 | 42.09 |
| 2026-08-03 | 38.21 |
| 2026-07-31 | 37.18 |
| 2026-07-30 | 38.42 |
| 2026-07-29 | 37.78 |
| 2026-07-28 | 42.06 |
| 2026-07-27 | 43.31 |
| 2026-07-24 | 41.70 |
| 2026-07-23 | 43.56 |
| 2026-07-22 | 40.49 |
| 2026-07-21 | 42.57 |
| 2026-07-20 | 38.50 |
| 2026-07-17 | 37.73 |
| 2026-07-16 | 38.65 |
| 2026-07-15 | 40.09 |
| 2026-07-14 | 39.16 |
| 2026-07-13 | 40.14 |
| 2026-07-10 | 44.36 |
| 2026-07-09 | 42.87 |
| 2026-07-08 | 43.00 |
| 2026-07-07 | 43.56 |
| 2026-07-06 | 43.39 |
| 2026-07-02 | 43.72 |
| 2026-07-01 | 43.69 |
| 2026-06-30 | 46.05 |
| 2026-06-29 | 46.05 |
| 2026-06-26 | 47.48 |
| 2026-06-25 | 43.46 |
| 2026-06-24 | 44.41 |
| 2026-06-23 | 44.77 |
| 2026-06-22 | 44.95 |
| 2026-06-18 | 45.25 |
| 2026-06-17 | 46.58 |
| 2026-06-16 | 45.92 |
| 2026-06-15 | 46.53 |
| 2026-06-12 | 45.84 |
| 2026-06-11 | 46.92 |
| 2026-06-10 | 44.95 |
| 2026-06-09 | 46.05 |
| 2026-06-08 | 44.20 |
| 2026-06-05 | 46.05 |
| 2026-06-04 | 47.20 |
| 2026-06-03 | 45.99 |
| 2026-06-02 | 43.51 |
| 2026-06-01 | 50.45 |
| 2026-05-29 | 52.82 |
| 2026-05-28 | 54.92 |
| 2026-05-27 | 53.18 |
| 2026-05-26 | 52.06 |
| 2026-05-22 | 53.05 |
| 2026-05-21 | 51.75 |
| 2026-05-20 | 48.37 |
| 2026-05-19 | 47.27 |
| 2026-05-18 | 47.45 |
| 2026-05-15 | 51.09 |
| 2026-05-14 | 54.31 |
| 2026-05-13 | 50.16 |
| 2026-05-12 | 47.22 |
| 2026-05-11 | 47.38 |
| 2026-05-08 | 34.90 |
| 2026-05-07 | 33.48 |
| 2026-05-06 | 33.59 |
| 2026-05-05 | 33.63 |
| 2026-05-04 | 33.33 |
| 2026-05-01 | 33.61 |
| 2026-04-30 | 41.61 |
| 2026-04-29 | 38.95 |
| 2026-04-28 | 44.57 |
| 2026-04-27 | 46.78 |
| 2026-04-24 | 46.13 |
| 2026-04-23 | 47.80 |
| 2026-04-22 | 50.18 |
| 2026-04-21 | 45.70 |
| 2026-04-20 | 40.35 |
| 2026-04-17 | 39.58 |
| 2026-04-16 | 36.18 |
| 2026-04-15 | 37.11 |
| 2026-04-14 | 36.31 |
| 2026-04-13 | 33.46 |
| 2026-04-10 | 33.80 |
| 2026-04-09 | 35.53 |
| 2026-04-08 | 34.08 |
| 2026-04-07 | 35.73 |
| 2026-04-06 | 36.05 |
| 2026-04-02 | 36.09 |
| 2026-04-01 | 35.94 |
| 2026-03-31 | 34.17 |
| 2026-03-30 | 30.91 |
| 2026-03-27 | 28.20 |
| 2026-03-26 | 25.11 |
| 2026-03-25 | 21.91 |
| 2026-03-24 | 19.42 |
| 2026-03-23 | 20.54 |
| 2026-03-20 | 20.27 |
| 2026-03-19 | 19.75 |
| 2026-03-18 | 19.25 |
| 2026-03-17 | 20.65 |
| 2026-03-16 | 21.54 |
| 2026-03-13 | 20.80 |
| 2026-03-12 | 21.50 |
| 2026-03-11 | 22.10 |
| 2026-03-10 | 23.34 |
| 2026-03-09 | 22.36 |
| 2026-03-06 | 22.45 |
| 2026-03-05 | 21.07 |
| 2026-03-04 | 21.37 |
| 2026-03-03 | 20.81 |
| 2026-03-02 | 20.83 |
| 2026-02-27 | 22.49 |
| 2025-02-13 | 1830.05 |
| 2025-02-12 | 1675.29 |
| 2025-02-11 | 1779.76 |
| 2025-02-10 | 1681.10 |
| 2025-02-07 | 1709.47 |
| 2025-02-06 | 1753.32 |
| 2025-02-05 | 1799.10 |
| 2025-02-04 | 1747.51 |
| 2025-02-03 | 1689.48 |
| 2025-01-31 | 1729.46 |
| 2025-01-30 | 1854.56 |
| 2025-01-29 | 1628.86 |
| 2025-01-28 | 1626.28 |
| 2025-01-27 | 1666.91 |
| 2025-01-24 | 1755.90 |
| 2025-01-23 | 1739.78 |
| 2025-01-22 | 1657.24 |
| 2025-01-21 | 1695.28 |
| 2025-01-17 | 1676.58 |
| 2025-01-16 | 1626.28 |
| 2025-01-15 | 1635.31 |
| 2025-01-14 | 1619.19 |
| 2025-01-13 | 1617.90 |
| 2025-01-10 | 1708.82 |
| 2025-01-08 | 1784.91 |
| 2025-01-07 | 1831.99 |
| 2025-01-06 | 1831.34 |
| 2025-01-03 | 1786.20 |
| 2025-01-02 | 1646.27 |
| 2024-12-31 | 1605.65 |
| 2024-12-30 | 1603.71 |
| 2024-12-27 | 1524.40 |
| 2024-12-26 | 1646.92 |
| 2024-12-24 | 1560.51 |
| 2024-12-23 | 1396.08 |
| 2024-12-20 | 1508.28 |
| 2024-12-19 | 1325.14 |
| 2024-12-18 | 1430.90 |
| 2024-12-17 | 1503.12 |
| 2024-12-16 | 1546.97 |
| 2024-12-13 | 1539.88 |
| 2024-12-12 | 1590.82 |
| 2024-12-11 | 1808.13 |
| 2024-12-10 | 1888.73 |
| 2024-12-09 | 1947.41 |
| 2024-12-06 | 1899.05 |
| 2024-12-05 | 1841.02 |
| 2024-12-04 | 1940.97 |
| 2024-12-03 | 1998.36 |
| 2024-12-02 | 2124.10 |
| 2024-11-29 | 2236.95 |
| 2024-11-27 | 2018.99 |
| 2024-11-26 | 2069.93 |
| 2024-11-25 | 1851.98 |
| 2024-11-22 | 2042.85 |
| 2024-11-21 | 2063.48 |
| 2024-11-20 | 2127.97 |
| 2024-11-19 | 2444.58 |
| 2024-11-18 | 2677.37 |
| 2024-11-15 | 2682.53 |
| 2024-11-14 | 2575.49 |
| 2024-11-13 | 2592.25 |
| 2024-11-12 | 2550.33 |
| 2024-11-11 | 2692.84 |
| 2024-11-08 | 2659.31 |
| 2024-11-07 | 2708.96 |
| 2024-11-06 | 2427.82 |
| 2024-11-05 | 2514.87 |
| 2024-11-04 | 2643.84 |
| 2024-11-01 | 2467.15 |
| 2024-10-31 | 2623.85 |
| 2024-10-30 | 2943.69 |
| 2024-10-29 | 3159.71 |
| 2024-10-28 | 1084.62 |
| 2024-10-25 | 1115.57 |
| 2024-10-24 | 1120.73 |
| 2024-10-23 | 1144.59 |
| 2024-10-22 | 1063.98 |
| 2024-10-21 | 1031.74 |
| 2024-10-18 | 1021.42 |
| 2024-10-17 | 1022.07 |
| 2024-10-16 | 1011.75 |
| 2024-10-15 | 982.73 |
| 2024-10-14 | 958.23 |
| 2024-10-11 | 967.90 |
| 2024-10-10 | 930.50 |
| 2024-10-09 | 925.34 |
| 2024-10-08 | 985.31 |
| 2024-10-07 | 1005.95 |
| 2024-10-04 | 1030.45 |
| 2024-10-03 | 1033.03 |
| 2024-10-02 | 993.05 |
| 2024-10-01 | 1069.14 |
| 2024-09-30 | 1089.78 |
| 2024-09-27 | 1076.88 |
| 2024-09-26 | 1099.45 |
| 2024-09-25 | 1028.52 |
| 2024-09-24 | 1060.76 |
| 2024-09-23 | 1060.76 |
| 2024-09-20 | 1062.69 |
| 2024-09-19 | 1096.22 |
| 2024-09-18 | 1057.53 |
| 2024-09-17 | 1063.98 |
| 2024-09-16 | 1045.93 |
| 2024-09-13 | 1096.22 |
| 2024-09-12 | 1057.53 |
| 2024-09-11 | 1047.22 |
| 2024-09-10 | 1023.36 |
Showing the most recent 260 of 2,153 data points. The chart above shows the full history.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.